[
  {
    "ts": null,
    "headline": "Humana Inc. stock outperforms competitors on strong trading day",
    "summary": "Humana Inc. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=be86d6cc5913001ca3ce7ff3e3f11a40cbc4ac2cd777e62bd40e852d00867ce0",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755881580,
      "headline": "Humana Inc. stock outperforms competitors on strong trading day",
      "id": 136518368,
      "image": "",
      "related": "HUM",
      "source": "MarketWatch",
      "summary": "Humana Inc. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=be86d6cc5913001ca3ce7ff3e3f11a40cbc4ac2cd777e62bd40e852d00867ce0"
    }
  },
  {
    "ts": null,
    "headline": "Can Elevance Health's Value-Based Care Strategy Fuel Long-Term Growth?",
    "summary": "ELV's focus on value-based care, Carelon integration and CareBridge acquisition drives membership and revenue growth.",
    "url": "https://finnhub.io/api/news?id=15ea7ca8a5ded831a04ac5b4ab30a5bab87e315a69a5f16f0b58fad74c03cbf1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755881580,
      "headline": "Can Elevance Health's Value-Based Care Strategy Fuel Long-Term Growth?",
      "id": 136478933,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "HUM",
      "source": "Yahoo",
      "summary": "ELV's focus on value-based care, Carelon integration and CareBridge acquisition drives membership and revenue growth.",
      "url": "https://finnhub.io/api/news?id=15ea7ca8a5ded831a04ac5b4ab30a5bab87e315a69a5f16f0b58fad74c03cbf1"
    }
  },
  {
    "ts": null,
    "headline": "UnitedHealth's Expansion Into ASCs: Redefining the Operating Room",
    "summary": "UNH is expanding its Optum surgery centers, cutting costs while boosting growth and patient access in value-based care.",
    "url": "https://finnhub.io/api/news?id=4c65390665305d6a5b519d1296e0edfe162a198cf0e493c2184a43903858bfa5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755881280,
      "headline": "UnitedHealth's Expansion Into ASCs: Redefining the Operating Room",
      "id": 136478934,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "HUM",
      "source": "Yahoo",
      "summary": "UNH is expanding its Optum surgery centers, cutting costs while boosting growth and patient access in value-based care.",
      "url": "https://finnhub.io/api/news?id=4c65390665305d6a5b519d1296e0edfe162a198cf0e493c2184a43903858bfa5"
    }
  },
  {
    "ts": null,
    "headline": "How the Cigna Deal Talks Are Shaping Humana’s 2025 Value Outlook",
    "summary": "Thinking about what to do with Humana stock right now? You are not alone. Healthcare stocks have been on a bit of a rollercoaster, and Humana has been no exception. Over the past month, the stock has jumped more than 27%, with a solid 30% gain over 90 days. Numbers like that tend to catch investors' attention. Still, if you take a step back, you will notice a challenging longer-term pattern, with the 1-year total return down roughly 16%. So what is going on beneath the surface? Humana has...",
    "url": "https://finnhub.io/api/news?id=0b8b0aba4666622e23c0a55f6f8a0d1a2895f3e97f83eb5b2df4704a45deb521",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755857588,
      "headline": "How the Cigna Deal Talks Are Shaping Humana’s 2025 Value Outlook",
      "id": 136476887,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "HUM",
      "source": "Yahoo",
      "summary": "Thinking about what to do with Humana stock right now? You are not alone. Healthcare stocks have been on a bit of a rollercoaster, and Humana has been no exception. Over the past month, the stock has jumped more than 27%, with a solid 30% gain over 90 days. Numbers like that tend to catch investors' attention. Still, if you take a step back, you will notice a challenging longer-term pattern, with the 1-year total return down roughly 16%. So what is going on beneath the surface? Humana has...",
      "url": "https://finnhub.io/api/news?id=0b8b0aba4666622e23c0a55f6f8a0d1a2895f3e97f83eb5b2df4704a45deb521"
    }
  }
]